Financials Sejong Medical Co., Ltd.

Equities

A258830

KR7258830009

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 19:00:00 2024-03-28 EDT 5-day change 1st Jan Change
412 KRW +26.77% Intraday chart for Sejong Medical Co., Ltd. -.--% -64.17%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 72,522 50,066 88,148 278,876 157,032 63,643
Enterprise Value (EV) 1 53,234 31,935 79,567 270,999 204,847 136,357
P/E ratio 17.7 x 14.5 x 190 x -47.2 x -1.35 x -2.75 x
Yield - 1.33% 0.73% - - -
Capitalization / Revenue 4.89 x 3.08 x 5.84 x 15.5 x 9.76 x 3.54 x
EV / Revenue 3.59 x 1.97 x 5.27 x 15 x 12.7 x 7.58 x
EV / EBITDA 13.1 x 6.33 x 68.4 x -227 x 1,048 x 101 x
EV / FCF -129 x -6.24 x -30.7 x -77.7 x 9.71 x -12.8 x
FCF Yield -0.78% -16% -3.26% -1.29% 10.3% -7.78%
Price to Book 1.66 x 1.08 x 1.96 x 5.02 x 5.89 x 3.68 x
Nbr of stocks (in thousands) 33,889 33,289 32,289 39,669 54,810 55,342
Reference price 2 2,140 1,504 2,730 7,030 2,865 1,150
Announcement Date 19-03-21 20-03-19 21-03-23 22-03-21 24-03-29 24-03-29
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 14,833 16,230 15,098 18,021 16,083 17,992
EBITDA 1 4,062 5,046 1,163 -1,192 195.4 1,349
EBIT 1 3,121 3,680 -636.2 -2,501 -1,226 -340.4
Operating Margin 21.04% 22.68% -4.21% -13.88% -7.62% -1.89%
Earnings before Tax (EBT) 1 4,357 3,704 -114.7 -5,209 -91,272 -25,393
Net income 1 3,787 3,464 470 -5,192 -91,982 -23,087
Net margin 25.53% 21.34% 3.11% -28.81% -571.92% -128.32%
EPS 2 121.1 104.0 14.40 -149.0 -2,123 -418.0
Free Cash Flow 1 -413.9 -5,118 -2,593 -3,488 21,094 -10,612
FCF margin -2.79% -31.54% -17.17% -19.36% 131.16% -58.98%
FCF Conversion (EBITDA) - - - - 10,794.04% -
FCF Conversion (Net income) - - - - - -
Dividend per Share - 20.00 20.00 - - -
Announcement Date 19-03-21 20-03-19 21-03-23 22-03-21 24-03-29 24-03-29
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 47,816 72,714
Net Cash position 1 19,288 18,131 8,581 7,877 - -
Leverage (Debt/EBITDA) - - - - 244.7 x 53.9 x
Free Cash Flow 1 -414 -5,118 -2,593 -3,488 21,094 -10,612
ROE (net income / shareholders' equity) 11.1% 6.91% 1.02% -11.6% -222% -105%
ROA (Net income/ Total Assets) 5.41% 4.8% -0.77% -2.15% -0.67% -0.16%
Assets 1 70,019 72,175 -61,151 241,158 13,773,858 14,077,258
Book Value Per Share 2 1,288 1,389 1,391 1,402 487.0 312.0
Cash Flow per Share 2 142.0 78.60 96.30 550.0 48.40 58.70
Capex 1 1,416 7,990 1,430 4,594 885 1,966
Capex / Sales 9.54% 49.23% 9.47% 25.5% 5.5% 10.93%
Announcement Date 19-03-21 20-03-19 21-03-23 22-03-21 24-03-29 24-03-29
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A258830 Stock
  4. Financials Sejong Medical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW